ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 057,80
0,00%
Dow Jones
38 852,86
-0,55%
DAX
18 684,66
0,00%
Brent Oil
84,265
-0,07%
Bitcoin
68 280,91
-0,01%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ikena Oncology Inc (IKNA)

  7. Ikena Oncology Inc (IKNA) Actualités

IKNA

Ikena Oncology (IKNA)

Ikena Oncology Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:IKNA
DateHeureSourceTitreSymboleSociété
28/05/202422h42GlobeNewswire Inc.UPDATE – Ikena Oncology Announces Strategic UpdateNASDAQ:IKNAIkena Oncology Inc
28/05/202422h24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
28/05/202422h15GlobeNewswire Inc.Ikena Oncology Announces Strategic UpdateNASDAQ:IKNAIkena Oncology Inc
13/05/202422h45GlobeNewswire Inc.Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate UpdateNASDAQ:IKNAIkena Oncology Inc
13/05/202422h33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IKNAIkena Oncology Inc
10/04/202414h00GlobeNewswire Inc.Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:IKNAIkena Oncology Inc
12/03/202413h00GlobeNewswire Inc.Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:IKNAIkena Oncology Inc
05/03/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
05/03/202422h01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
27/02/202414h00GlobeNewswire Inc.Ikena Oncology to Participate in TD Cowen 44th Annual Health Care ConferenceNASDAQ:IKNAIkena Oncology Inc
21/02/202422h15GlobeNewswire Inc.Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical OfficerNASDAQ:IKNAIkena Oncology Inc
18/01/202422h05GlobeNewswire Inc.Ikena Oncology Outlines Key Priorities and Provides Corporate UpdatesNASDAQ:IKNAIkena Oncology Inc
09/11/202313h00GlobeNewswire Inc.Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial ResultsNASDAQ:IKNAIkena Oncology Inc
07/11/202314h00GlobeNewswire Inc.Ikena Oncology to Present at Multiple November 2023 Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
25/09/202322h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:IKNAIkena Oncology Inc
15/09/202322h05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:IKNAIkena Oncology Inc
12/09/202322h11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IKNAIkena Oncology Inc
11/09/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IKNAIkena Oncology Inc
05/09/202314h00GlobeNewswire Inc.Ikena Oncology to Participate in September 2023 Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
18/08/202322h03Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:IKNAIkena Oncology Inc
18/08/202322h02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IKNAIkena Oncology Inc
10/08/202314h00GlobeNewswire Inc.Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate UpdateNASDAQ:IKNAIkena Oncology Inc
07/08/202313h00GlobeNewswire Inc.Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock TransactionNASDAQ:IKNAIkena Oncology Inc
13/06/202322h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IKNAIkena Oncology Inc
09/06/202322h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IKNAIkena Oncology Inc
24/05/202314h00GlobeNewswire Inc.Ikena Oncology to Participate in Upcoming Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
15/05/202313h50GlobeNewswire Inc.Ikena Oncology Reports First Quarter 2023 Financial Results and Highlights Advancements Across Targeted Oncology PipelineNASDAQ:IKNAIkena Oncology Inc
15/05/202313h45GlobeNewswire Inc.Ikena Oncology Announces $40 Million Underwritten OfferingNASDAQ:IKNAIkena Oncology Inc
15/05/202313h27Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IKNAIkena Oncology Inc
15/05/202312h36Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IKNAIkena Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:IKNA

Dernières Valeurs Consultées

NASDAQ
WFFAEX
Flex Focus Conservative ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés